MediciNova Inc (MNOV)
Drugs • Health Care
Percentage
Change
| Feb 06 | Feb 07 | Mar 08 | Mar 09 | Mar 10 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 15 | Feb 16 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 22 | Feb 23 | Feb 24 | Feb 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -11 | -12 | |||||||||||||||||||
Net Income | -11 | -12 | |||||||||||||||||||
Profit | -11 | -12 | |||||||||||||||||||
Net Income Continuing | -11 | -12 | |||||||||||||||||||
Income Tax Expense | -0 | -0 | |||||||||||||||||||
Pretax Income | -11 | -12 | |||||||||||||||||||
Total Non-operating Income | 2 | 1 | |||||||||||||||||||
Operating Income | -13 | -13 | |||||||||||||||||||
Total Revenue | 0 | 0 | |||||||||||||||||||
Total Costs and Expenses | -13 | -14 | |||||||||||||||||||
Operating Expenses | -13 | -14 | |||||||||||||||||||
Research and Development Expenses | -7 | -7 | |||||||||||||||||||
Selling, General & Administrative Expenses | -5 | -7 |